Powered by OpenAIRE graph

NILVAD

A European multicentre double-blind placebo-controlled phase III trial of nilvadIpine in mild to moderate Alzheimer’s disease
image/svg+xml art designer at PLoS, modified by Wikipedia users Nina, Beao, JakobVoss, and AnonMoos Open Access logo, converted into svg, designed by PLoS. This version with transparent background. http://commons.wikimedia.org/wiki/File:Open_Access_logo_PLoS_white.svg art designer at PLoS, modified by Wikipedia users Nina, Beao, JakobVoss, and AnonMoos http://www.plos.org/ Open Access Mandate for Publications assignment_turned_inproject01 Jan 2012(Started)-30 Jun 2017(Ended)Closed
Funder: European CommissionProject code: 279093 Call for proposal: FP7-HEALTH-2011-two-stage
Funded under: FP7 | SP1 | HEALTH
Detailed project information (CORDIS)
visibility
download
views
OpenAIRE UsageCountsViews provided by UsageCounts
downloads
OpenAIRE UsageCountsDownloads provided by UsageCounts
5
3
Data Management Plans
argos Start a new DMP in Argos
  • OpenAIRE UsageCounts
    Usage byUsageCounts
    visibility views 5
    download downloads 3
  • 5
    views
    3
    downloads
    Powered byOpenAIRE UsageCounts
Powered by OpenAIRE graph

Do the share buttons not appear? Please make sure, any blocking addon is disabled, and then reload the page.

All Research products
arrow_drop_down
<script type="text/javascript">
<!--
document.write('<div id="oa_widget"></div>');
document.write('<script type="text/javascript" src="https://www.openaire.eu/index.php?option=com_openaire&view=widget&format=raw&projectId=corda_______::caf24505b7c477c6bc7132cd8a27e709&type=result"></script>');
-->
</script>
COPY SCRIPT
For further information contact us at helpdesk@openaire.eu

No option selected
arrow_drop_down